《赛诺菲Sanofi（SNY）2025年美国处方药定价原则报告「NYSE」（英文版）（7页）.pdf》由会员分享，可在线阅读，更多相关《赛诺菲Sanofi（SNY）2025年美国处方药定价原则报告「NYSE」（英文版）（7页）.pdf（7页珍藏版）》请在三个皮匠报告上搜索。

1、Our goalthen and nowis to foster a culture of transparency that helps our stakeholders better understand our pricing decisions and facilitates a more informed discussion related to the pricing of medicines across the U.S.healthcare system.This report outlines our principles,2024 pricing decisions,an

2、d our perspectives on advancing solutions to improve patient outcomes and affordability in the United States.At Sanofi,we work passionately to help prevent,treat,and cure illness and disease,understand and solve healthcare needs of people across the world,and transform the practice of medicine.We ha

3、ve a longstanding commitment to promoting healthcare systems that make our treatments accessible and affordable to those in need.In May 2017,Sanofi reinforced this commitment with the introduction of our Pricing Principles,which details how we price our medicines and advocates for policy solutions t

4、o make the system work better for patients.Advancing Responsible Leadership2025 Pricing Principles Reportof U.S.healthcare spending,marking a reduction of approximately 4%compared to the previous year.1As of September 2024,prescription medicines accounted for only commitment to patient access while

5、minimizing our contribution to overall healthcare system spending.We remain transparent in how we price our prescription medicines and limit price increases in the United States.At Sanofi,we price our medicines according to their value while advancing broader solutions that improve patient outcomes

6、and support affordability within the U.S.healthcare system.Our pricing strategy underscores our 1 Altarum.Health Sector Economic Indicators.November 2024.We share concerns about patients affordability of medicines while recognizing that we are only one of many stakeholders involved in healthcare del